Standard of Care sensibility: PD1 / PDL1 / Gemcitabine
Acquired resistance to: PD1 / PDL1 / Gemcitabine
Tumour model
Standard of Care sensibility: PD1 / PDL1 / Gemcitabine
Acquired resistance to: PD1 / PDL1 / Gemcitabine
Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.
Other models sharing the same tissue of origin.